Raymond R Carrillo, MD
Nephrology · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 9 carriers
- Offices
- 2
Offices
2 locations · Central Coast Nephrology Medical Corporation · 11 clinicians in this group
Looking this up.
Hospitals listed: 052751 · 552724 · 752547 · Hazel Hawkins Memorial Hospital · Natividad Medical Center · Salinas Valley Health Medical Center · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
29 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carrillo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Hazel Hawkins Memorial HospitalHollister, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
- Natividad Medical CenterSalinas, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Natividad Medical CenterPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Hazel Hawkins Memorial Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.1) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 43 cases | No different | Jan 2024 – Dec 2024 |
See every measure and the patient survey for Natividad Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 332 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.76 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.77 (109.76 to 221.78) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 609 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.36 (2.03 to 6.7) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.71) · 555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.67 (1.19 to 20.15) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (0.71 to 9.12) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.07 (0.12 to 2.02) · 1,742 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.462 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 93 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.9) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (966 patients answered, 55% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,071,099
Medicare paid this office $1,071,099 for 730 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $113,875 | $321 |
| Injection, inclisiran, 1 mg | 15 | $45,837 | None |
| Return visit (30+ min) | 283 | $35,566 | $70 |
| Home dialysis services per month (20 years or older) | 19 | $34,938 | $250 |
| Injection, denosumab, 1 mg | 24 | $30,097 | None |
See all 23 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $113,875 | $321 |
| Injection, inclisiran, 1 mg | 15 | $45,837 | None |
| Return visit (30+ min) | 283 | $35,566 | $70 |
| Home dialysis services per month (20 years or older) | 19 | $34,938 | $250 |
| Injection, denosumab, 1 mg | 24 | $30,097 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 198 | $26,341 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $17,866 | $263 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $10,181 | $139 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 16 | $8,264 | None |
| Hemodialysis procedure with physician evaluation | 78 | $6,597 | $58 |
| New patient visit (45+ min) | 48 | $6,434 | $134 |
| Dialysis procedure including 1 evaluation | 29 | $5,861 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 40 | $3,894 | $56 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 19 | $2,596 | $0 |
| Injection of drug or substance under skin or into muscle | 68 | $2,461 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $1,988 | $110 |
| Short return visit (20+ min) | 19 | $1,341 | $64 |
| Complete ultrasound scan behind abdominal cavity | 14 | $1,075 | $77 |
| Influenza vaccine split virus, preservative free | 14 | $1,054 | $75 |
| Insertion of needle into vein for collection of blood sample | 65 | $1,038 | $9 |
| Kidney function blood test panel | 56 | $638 | $9 |
| Administration of chemotherapy into vein, each additional hour | 15 | $611 | $23 |
| Administration of influenza virus vaccine | 16 | $508 | $32 |
Who their Medicare patients are
730 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 13% · Women 47% · Also on Medicaid 49% · Health risk score 4.23. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 68% · Heart failure 44% · Coronary heart disease 40% · Atrial fibrillation 28% · Depression 24% · COPD 18% · Stroke 13% · Cancer 11% · Dementia 9%.
The office billed $2,326,955, Medicare allowed $1,363,672 and paid $1,071,099; for 39,875 services of 63 kinds; $792,534 of it was for drugs given in the office and $278,565 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 730 | 39,875 | 73 | 4.23 | $2,326,955 | $1,071,099 |
| 2023 | 781 | 25,538 | 72 | 4.27 | $1,361,881 | $672,644 |
| 2022 | 796 | 31,310 | 73 | 3.72 | $1,408,232 | $679,477 |
| 2021 | 843 | 34,701 | 72 | 3.82 | $1,614,069 | $781,886 |
| 2020 | 892 | 27,424 | 72 | 4.08 | $1,469,199 | $670,795 |
| 2019 | 843 | 22,470 | 72 | 4.42 | $1,045,857 | $476,782 |
| 2018 | 879 | 22,117 | 71 | 4.39 | $1,086,788 | $512,439 |
| 2017 | 885 | 24,463 | 71 | 4.31 | $1,068,175 | $504,430 |
| 2016 | 901 | 25,311 | 71 | 4.08 | $1,193,323 | $543,948 |
| 2015 | 923 | 18,336 | 71 | 3.94 | $1,124,521 | $523,859 |
| 2014 | 898 | 20,859 | 72 | 3.61 | $921,878 | $434,480 |
| 2013 | 896 | 24,143 | 71 | 3.79 | $838,903 | $407,085 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $85,941 | $324 |
| Injection, denosumab, 1 mg | 36 | $41,733 | None |
| Home dialysis services per month (20 years or older) | 24 | $39,827 | $255 |
| Return visit (30+ min) | 272 | $36,296 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 233 | $31,619 | $67 |
| Injection, romosozumab-aqqg, 1 mg | 11 | $22,891 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $14,438 | $149 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $12,812 | $261 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 21 | $12,489 | None |
| Hemodialysis procedure with physician evaluation | 108 | $9,537 | $59 |
| New patient visit (45+ min) | 47 | $5,772 | $123 |
| Dialysis procedure including 1 evaluation | 27 | $5,674 | $73 |
| Injection of drug or substance under skin or into muscle | 77 | $3,769 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 24 | $2,363 | $56 |
| Influenza vaccine split virus, preservative free | 25 | $1,723 | $69 |
| Short return visit (20+ min) | 46 | $1,721 | $34 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,542 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $877 | $49 |
| Insertion of needle into vein for collection of blood sample | 68 | $790 | $8 |
| Administration of influenza virus vaccine | 26 | $721 | $28 |
| Kidney function blood test panel | 56 | $613 | $9 |
| Blood count, hemoglobin | 15 | $86 | $2 |
| Urinalysis, manual test | 22 | $75 | $3 |
| Red blood cell concentration measurement | 14 | $58 | $2 |
2022: 24 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 58 | $102,076 | $332 |
| Injection, denosumab, 1 mg | 34 | $37,303 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 237 | $33,558 | $62 |
| Home dialysis services per month (20 years or older) | 20 | $33,275 | $271 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $16,633 | $277 |
| Return visit (30+ min) | 141 | $16,501 | $79 |
| Short return visit (20+ min) | 231 | $16,329 | $46 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 55 | $12,878 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $12,072 | $168 |
| Hemodialysis procedure with physician evaluation | 82 | $7,068 | $63 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 16 | $5,597 | $1 |
| Dialysis procedure including 1 evaluation | 25 | $4,703 | $76 |
| New patient visit (45+ min) | 34 | $4,284 | $126 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 32 | $3,658 | $62 |
| Injection of drug or substance under skin or into muscle | 96 | $3,173 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $2,901 | $64 |
| Administration of chemotherapy into vein, 1 hour or less | 15 | $2,820 | $118 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,146 | $113 |
| Administration of chemotherapy into vein, each additional hour | 15 | $978 | $26 |
| Kidney function blood test panel | 80 | $742 | $9 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $422 | $30 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $366 | $33 |
| Insertion of needle into vein for collection of blood sample | 102 | $350 | $3 |
| Blood count, hemoglobin | 38 | $205 | $2 |
2021: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 72 | $132,784 | $334 |
| Short return visit (20+ min) | 257 | $32,264 | $68 |
| Home dialysis services per month (20 years or older) | 24 | $31,623 | $264 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 253 | $31,067 | $61 |
| Injection, denosumab, 1 mg | 30 | $31,038 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $22,640 | $280 |
| Return visit (30+ min) | 80 | $14,260 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $13,898 | $167 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 53 | $13,135 | None |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 25 | $10,358 | $1 |
| New patient visit (45+ min) | 48 | $6,312 | $131 |
| Hemodialysis procedure with physician evaluation | 75 | $5,889 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 41 | $4,719 | $60 |
| Dialysis procedure including 1 evaluation | 19 | $4,335 | $76 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $3,407 | $122 |
| Injection of drug or substance under skin or into muscle | 91 | $3,067 | $12 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,714 | $113 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $1,695 | $46 |
| Complete ultrasound scan behind abdominal cavity | 12 | $1,218 | $102 |
| Administration of chemotherapy into vein, each additional hour | 16 | $1,049 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $978 | $33 |
| Kidney function blood test panel | 79 | $845 | $9 |
| Short return visit | 13 | $587 | $39 |
| Insertion of needle into vein for collection of blood sample | 98 | $369 | $3 |
| Blood count, hemoglobin | 46 | $214 | $2 |
| Blood test, comprehensive group of blood chemicals | 14 | $161 | $9 |
| Urinalysis, manual test | 18 | $60 | $3 |
2020: 30 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 86 | $128,766 | $269 |
| Injection, denosumab, 1 mg | 60 | $59,317 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 261 | $35,469 | $62 |
| Home dialysis services per month (20 years or older) | 20 | $27,444 | $218 |
| Short return visit (20+ min) | 261 | $25,498 | $55 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $22,562 | $228 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 57 | $14,228 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,177 | $175 |
| Return visit (30+ min) | 89 | $12,789 | $85 |
| Hemodialysis procedure with physician evaluation | 100 | $10,274 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $5,009 | $111 |
| Dialysis procedure including 1 evaluation | 23 | $4,651 | $75 |
| New patient visit (45+ min) | 25 | $3,486 | $139 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 27 | $3,209 | $58 |
| Injection of drug or substance under skin or into muscle | 125 | $3,192 | $12 |
| Short return visit | 79 | $2,537 | $29 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $2,157 | $127 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,940 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $1,422 | $33 |
| Telephone medical discussion with physician, 5-10 minutes | 28 | $1,276 | $43 |
| Kidney function blood test panel | 117 | $1,227 | $9 |
| Complete ultrasound scan behind abdominal cavity | 11 | $1,020 | $93 |
| Influenza vaccine split virus, preservative free | 16 | $976 | $61 |
| Administration of chemotherapy into vein, each additional hour | 11 | $623 | $27 |
| Administration of influenza virus vaccine | 30 | $541 | $18 |
| Insertion of needle into vein for collection of blood sample | 138 | $511 | $3 |
| Blood test, comprehensive group of blood chemicals | 19 | $211 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $174 | $13 |
| Blood count, hemoglobin | 46 | $156 | $2 |
| Urinalysis, manual test | 11 | $38 | $3 |
2019: 25 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 102 | $126,422 | $256 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 279 | $38,516 | $59 |
| Short return visit (20+ min) | 301 | $31,094 | $54 |
| Injection, denosumab, 1 mg | 33 | $30,733 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 60 | $25,542 | $215 |
| Home dialysis services per month (20 years or older) | 20 | $23,972 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $14,296 | $164 |
| Hemodialysis procedure with physician evaluation | 125 | $12,349 | $61 |
| Return visit (30+ min) | 81 | $9,097 | $86 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 34 | $6,092 | None |
| New patient visit (45+ min) | 36 | $4,896 | $136 |
| Dialysis procedure including 1 evaluation | 20 | $4,124 | $71 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 11 | $3,960 | $1 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,666 | $115 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 24 | $2,388 | $60 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,251 | $173 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 46 | $2,100 | $32 |
| Injection of drug or substance under skin or into muscle | 76 | $1,632 | $13 |
| Short return visit | 45 | $1,541 | $30 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,220 | $61 |
| Kidney function blood test panel | 84 | $927 | $9 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 23 | $607 | $26 |
| Administration of influenza virus vaccine | 24 | $423 | $18 |
| Insertion of needle into vein for collection of blood sample | 101 | $356 | $3 |
| Blood count, hemoglobin | 20 | $63 | $3 |
2018: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 104 | $139,665 | $253 |
| Injection, denosumab, 1 mg | 53 | $49,540 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 276 | $40,711 | $60 |
| Short return visit (20+ min) | 302 | $30,008 | $53 |
| Home dialysis services per month (20 years or older) | 21 | $23,956 | $208 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 67 | $23,637 | $217 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 49 | $22,039 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $16,724 | $162 |
| Hemodialysis procedure with physician evaluation | 154 | $15,277 | $59 |
| Return visit (30+ min) | 61 | $8,526 | $82 |
| Injection of drug or substance under skin or into muscle | 104 | $4,512 | $17 |
| New patient visit (45+ min) | 37 | $4,448 | $120 |
| Hospital discharge day management, 30 minutes or less | 57 | $3,840 | $59 |
| Dialysis procedure including 1 evaluation | 23 | $3,575 | $70 |
| Hospital discharge day management, more than 30 minutes | 37 | $3,454 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,795 | $112 |
| Short return visit | 76 | $2,550 | $30 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $2,140 | $32 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $1,874 | $60 |
| Kidney function blood test panel | 105 | $1,294 | $10 |
| Complete ultrasound scan behind abdominal cavity | 13 | $996 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $902 | $82 |
| Insertion of needle into vein for collection of blood sample | 117 | $412 | $3 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 19 | $401 | $21 |
| Administration of influenza virus vaccine | 19 | $382 | $20 |
| Blood count, hemoglobin | 34 | $198 | $3 |
| Urinalysis, manual test | 17 | $55 | $3 |
2017: 30 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 94 | $121,721 | $253 |
| Injection, denosumab, 1 mg | 48 | $41,600 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 289 | $41,431 | $58 |
| Home dialysis services per month (20 years or older) | 25 | $30,550 | $204 |
| Short return visit (20+ min) | 286 | $28,385 | $53 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $27,808 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 124 | $21,788 | $161 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 50 | $13,646 | None |
| Hemodialysis procedure with physician evaluation | 128 | $12,895 | $57 |
| Return visit (30+ min) | 71 | $10,041 | $85 |
| New patient visit (45+ min) | 34 | $4,576 | $135 |
| Injection of drug or substance under skin or into muscle | 100 | $3,884 | $22 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 11 | $3,661 | $1 |
| Hospital discharge day management, more than 30 minutes | 39 | $3,558 | $83 |
| Hospital discharge day management, 30 minutes or less | 52 | $3,279 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,760 | $110 |
| Dialysis procedure including 1 evaluation | 14 | $2,625 | $66 |
| Short return visit | 80 | $2,338 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 26 | $2,242 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 47 | $2,106 | $31 |
| Kidney function blood test panel | 102 | $1,294 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,154 | $89 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $1,143 | $7 |
| Complete ultrasound scan behind abdominal cavity | 13 | $1,014 | $78 |
| Administration of influenza virus vaccine | 27 | $647 | $23 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 27 | $451 | $16 |
| Insertion of needle into vein for collection of blood sample | 105 | $338 | $3 |
| Hemoglobin a1c level | 12 | $170 | $13 |
| Blood count, hemoglobin | 25 | $108 | $3 |
| Urinalysis, manual test | 16 | $55 | $3 |
2016: 28 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 91 | $131,041 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 281 | $41,647 | $56 |
| Injection, denosumab, 1 mg | 49 | $35,804 | None |
| Home dialysis services per month (20 years or older) | 21 | $33,278 | $191 |
| Short return visit (20+ min) | 292 | $31,335 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $21,556 | $156 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 49 | $20,584 | $210 |
| Hemodialysis procedure with physician evaluation | 140 | $13,979 | $56 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 51 | $12,488 | None |
| Return visit (30+ min) | 55 | $7,091 | $85 |
| Hospital discharge day management, more than 30 minutes | 44 | $4,632 | $84 |
| Dialysis procedure including 1 evaluation | 18 | $4,497 | $68 |
| New patient visit (45+ min) | 30 | $3,878 | $129 |
| Injection of drug or substance under skin or into muscle | 102 | $3,608 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,993 | $111 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 24 | $2,808 | $57 |
| Short return visit | 88 | $2,633 | $28 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,315 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 66 | $2,173 | $28 |
| Kidney function blood test panel | 111 | $1,540 | $11 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $1,177 | $7 |
| Administration of influenza virus vaccine | 23 | $613 | $27 |
| Insertion of needle into vein for collection of blood sample | 127 | $459 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 23 | $388 | $17 |
| Blood test, comprehensive group of blood chemicals | 14 | $196 | $13 |
| Hemoglobin a1c level | 12 | $156 | $13 |
| Blood count, hemoglobin | 28 | $124 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 23 | $89 | $4 |
2015: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 104 | $147,082 | $252 |
| Injection, denosumab, 1 mg | 45 | $35,168 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 279 | $34,848 | $59 |
| Short return visit (20+ min) | 310 | $32,656 | $54 |
| Home dialysis services per month (20 years or older) | 23 | $27,450 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $23,323 | $167 |
| Hemodialysis procedure with physician evaluation | 125 | $13,757 | $59 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 45 | $13,222 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $12,632 | $214 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,953 | $113 |
| New patient visit (45+ min) | 33 | $4,401 | $133 |
| Injection of drug or substance under skin or into muscle | 91 | $3,807 | $21 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 73 | $3,691 | $32 |
| Return visit (30+ min) | 33 | $3,428 | $80 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,376 | $57 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,251 | $88 |
| Short return visit | 93 | $3,166 | $29 |
| Dialysis procedure including 1 evaluation | 15 | $2,067 | $71 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $1,907 | $56 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $1,748 | $6 |
| Kidney function blood test panel | 118 | $1,601 | $11 |
| Administration of influenza virus vaccine | 27 | $718 | $27 |
| Insertion of needle into vein for collection of blood sample | 142 | $521 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 27 | $367 | $14 |
| Blood test, comprehensive group of blood chemicals | 17 | $245 | $13 |
| Blood count, hemoglobin | 40 | $187 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 38 | $160 | $4 |
2014: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 90 | $136,496 | $252 |
| Short return visit (20+ min) | 302 | $32,967 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $31,902 | $58 |
| Home dialysis services per month (20 years or older) | 20 | $30,251 | $203 |
| Injection, denosumab, 1 mg | 40 | $28,180 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 116 | $20,042 | $166 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 56 | $15,766 | None |
| Hemodialysis procedure with physician evaluation | 121 | $12,605 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $8,700 | $212 |
| Return visit (30+ min) | 62 | $6,671 | $74 |
| New patient visit (45+ min) | 38 | $5,153 | $136 |
| Injection of drug or substance under skin or into muscle | 99 | $4,375 | $20 |
| Dialysis services, per day, less than full month service (20 years or older) | 19 | $3,588 | $7 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 82 | $3,261 | $31 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,247 | $112 |
| Dialysis procedure including 1 evaluation | 19 | $3,190 | $63 |
| Hospital discharge day management, more than 30 minutes | 32 | $2,863 | $84 |
| Hospital discharge day management, 30 minutes or less | 42 | $2,835 | $58 |
| Short return visit | 70 | $2,349 | $31 |
| Complete ultrasound scan behind abdominal cavity | 19 | $2,207 | $116 |
| Kidney function blood test panel | 133 | $2,042 | $11 |
| Administration of influenza virus vaccine | 30 | $784 | $26 |
| Insertion of needle into vein for collection of blood sample | 156 | $660 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 30 | $410 | $14 |
| Blood count, hemoglobin | 55 | $261 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 49 | $207 | $4 |
| Hemoglobin a1c level | 14 | $195 | $13 |
2013: 31 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 93 | $150,213 | $249 |
| Return visit (30+ min) | 241 | $44,188 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 289 | $38,899 | $56 |
| Home dialysis services per month (20 years or older) | 19 | $28,309 | $199 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 145 | $24,973 | $159 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 57 | $17,661 | None |
| Hemodialysis procedure with physician evaluation | 140 | $15,363 | $56 |
| Short return visit (20+ min) | 173 | $12,032 | $54 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 33 | $11,843 | $211 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 23 | $8,180 | $1 |
| New patient visit (45+ min) | 32 | $4,152 | $130 |
| Injection of drug or substance under skin or into muscle | 61 | $4,124 | $22 |
| Hospital discharge day management, 30 minutes or less | 58 | $3,808 | $57 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,466 | $85 |
| Dialysis procedure including 1 evaluation | 17 | $3,298 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 85 | $3,041 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,865 | $110 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 26 | $2,232 | $62 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 12 | $2,222 | $148 |
| Dialysis services, per day, less than full month service (20 years or older) | 19 | $2,193 | $6 |
| Kidney function blood test panel | 124 | $2,130 | $12 |
| New patient visit (60+ min) | 11 | $1,867 | $170 |
| Complete ultrasound scan behind abdominal cavity | 15 | $1,697 | $113 |
| Administration of influenza virus vaccine | 29 | $811 | $26 |
| Insertion of needle into vein for collection of blood sample | 138 | $652 | $3 |
| Short return visit | 15 | $468 | $31 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 23 | $279 | $12 |
| Blood count, hemoglobin | 41 | $240 | $3 |
| Blood test, comprehensive group of blood chemicals | 12 | $226 | $14 |
| Manual urinalysis test with examination using microscope, non-automated | 46 | $200 | $4 |
| Hemoglobin a1c level | 13 | $180 | $13 |
Medicaid work
$50,213 in 2024
Medicaid paid $50,213 for 741 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 279 | $31,529 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 319 | $8,572 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 51 | $6,609 |
| Return visit (30+ min) | 92 | $3,503 |
| 2024 | 741 | 4 | 34 | $50,213 |
| 2023 | 1,249 | 8 | 40 | $46,925 |
| 2022 | 2,939 | 12 | 47 | $35,772 |
| 2021 | 6,627 | 17 | 39 | $48,148 |
| 2020 | 7,657 | 16 | 36 | $44,451 |
| 2019 | 8,716 | 16 | 46 | $59,516 |
| 2018 | 7,779 | 16 | 36 | $45,931 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 454 | $15,228 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 123 | $10,158 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 189 | $9,894 |
| Return visit (30+ min) | 193 | $8,244 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 60 | $1,840 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $964 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $597 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 193 | $0 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 574 | $15,233 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 157 | $10,490 |
| Darbepoetin alfa, esrd use | 144 | $5,208 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 49 | $1,689 |
| Return visit (30+ min) | 30 | $1,008 |
| Iron sucrose injection | 80 | $858 |
| Short return visit (20+ min) | 42 | $857 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 17 | $293 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 29 | $86 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $51 |
| Protein, total, except by refractometry; serum, plasma or whole blood | 12 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,793 | $0 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 518 | $15,340 |
| Darbepoetin alfa, esrd use | 825 | $14,502 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 141 | $10,234 |
| Iron sucrose injection | 576 | $3,657 |
| Short return visit (20+ min) | 106 | $2,528 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 45 | $1,815 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose | 17 | $40 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 15 | $31 |
| Creatinine; blood | 14 | $0 |
| Measurement of alkaline phosphatase | 29 | $0 |
| Phosphorus inorganic (phosphate) | 42 | $0 |
| Protein, total, except by refractometry; serum, plasma or whole blood | 72 | $0 |
2020
| Darbepoetin alfa, esrd use | 834 | $18,243 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 477 | $11,764 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 142 | $7,897 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 84 | $3,740 |
| Short return visit (20+ min) | 106 | $2,057 |
| Iron sucrose injection | 335 | $626 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 20 | $124 |
| CALCIUM TOTAL | 25 | $0 |
| Creatinine; blood | 74 | $0 |
| Measurement of alkaline phosphatase | 78 | $0 |
| Phosphorus inorganic (phosphate) | 78 | $0 |
| Protein, total, except by refractometry; serum, plasma or whole blood | 83 | $0 |
2019
| Darbepoetin alfa, esrd use | 1,034 | $24,844 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 579 | $15,779 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 157 | $8,876 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 122 | $4,758 |
| Short return visit (20+ min) | 131 | $3,101 |
| Iron sucrose injection | 439 | $1,836 |
| Return visit (30+ min) | 15 | $322 |
| Creatinine; blood | 26 | $0 |
| Measurement of alkaline phosphatase | 42 | $0 |
| Phosphorus inorganic (phosphate) | 55 | $0 |
| Protein, total, except by refractometry; serum, plasma or whole blood | 69 | $0 |
| Urea nitrogen; quantitative | 107 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 541 | $16,639 |
| Darbepoetin alfa, esrd use | 749 | $9,350 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 185 | $7,294 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 151 | $4,855 |
| Iron sucrose injection | 418 | $3,453 |
| Short return visit (20+ min) | 114 | $2,337 |
| 1ST HOSP IP/OBS HIGH 75 | 29 | $2,003 |
| Measurement of alkaline phosphatase | 36 | $0 |
| Phosphorus inorganic (phosphate) | 63 | $0 |
| Protein, total, except by refractometry; serum, plasma or whole blood | 68 | $0 |
| Measurement of transferrin | 12 | $0 |
| Urea nitrogen; quantitative | 195 | $0 |
Drugs they prescribed that Part D paid
$208,996
Pharmacies billed $208,996 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,224 generic and 189 brand-name prescriptions · $208,996 in drug cost · 41 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Veltassa | 56 | $56,354 | $1,006 |
| Velphoro | 15 | $37,712 | $2,514 |
| Sevelamer Carbonate | 51 | $17,406 | $341 |
| Eliquis | 13 | $8,537 | $657 |
| Calcium Acetate | 70 | $6,092 | $87 |
See all 33 drugs
| Veltassa | 56 | $56,354 | $1,006 |
| Velphoro | 15 | $37,712 | $2,514 |
| Sevelamer Carbonate | 51 | $17,406 | $341 |
| Eliquis | 13 | $8,537 | $657 |
| Calcium Acetate | 70 | $6,092 | $87 |
| Cinacalcet | 18 | $4,156 | $231 |
| Ultra-Fine Short Pen Needle | 25 | $1,414 | $57 |
| Bumetanide | 25 | $882 | $35 |
| Hydralazine | 61 | $845 | $14 |
| Amlodipine Besylate | 97 | $811 | $8 |
| Doxazosin Mesylate | 24 | $726 | $30 |
| Tamsulosin | 54 | $637 | $12 |
| Furosemide | 84 | $597 | $7 |
| Losartan | 62 | $484 | $8 |
| Nifedipine Er | 11 | $444 | $40 |
| Calcitriol | 15 | $421 | $28 |
| Omeprazole | 17 | $391 | $23 |
| Carvedilol | 22 | $301 | $14 |
| Gabapentin | 30 | $291 | $10 |
| Valsartan | 13 | $265 | $20 |
| Atorvastatin | 28 | $248 | $9 |
| Metoprolol | 31 | $230 | $7 |
| Metoprolol | 20 | $204 | $10 |
| Pantoprazole | 34 | $185 | $5 |
| Allopurinol | 19 | $183 | $10 |
| Lactulose | 19 | $178 | $9 |
| Lisinopril | 42 | $176 | $4 |
| Metformin | 13 | $145 | $11 |
| Prednisone | 29 | $139 | $5 |
| Hydrochlorothiazide | 19 | $136 | $7 |
| Paroxetine | 13 | $88 | $7 |
| Simvastatin | 15 | $68 | $5 |
| Glipizide | 12 | $33 | $3 |
Year by year
| 2024 | 1,441 | 193 | None | 13% | $208,996 |
| 2023 | 1,456 | 202 | None | 14% | $282,824 |
| 2022 | 1,596 | 217 | 0% (0) | 15% | $351,680 |
| 2021 | 2,164 | 294 | None | 12% | $358,898 |
| 2020 | 2,027 | 290 | 1% (28) | 13% | $265,775 |
| 2019 | 1,985 | 248 | 2% (45) | 11% | $232,019 |
| 2018 | 2,681 | 271 | 4% (102) | 14% | $389,559 |
| 2017 | 3,050 | 254 | 3% (93) | 18% | $595,305 |
| 2016 | 3,385 | 253 | 4% (123) | 22% | $678,455 |
| 2015 | 3,781 | 256 | 4% (147) | 26% | $652,306 |
| 2014 | 3,833 | 262 | 4% (165) | 29% | $572,458 |
| 2013 | 4,295 | 305 | 4% (173) | 31% | $598,797 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Renvela | 11 | $29,365 | $2,670 |
| Velphoro | 16 | $27,774 | $1,736 |
| Sevelamer Carbonate | 38 | $24,505 | $645 |
| Veltassa | 20 | $22,851 | $1,143 |
| Auryxia | 11 | $20,634 | $1,876 |
| Tradjenta | 14 | $15,843 | $1,132 |
| Novolog Flexpen | 21 | $13,107 | $624 |
| Eliquis | 16 | $12,936 | $809 |
| Cinacalcet | 14 | $7,498 | $536 |
| Calcium Acetate | 41 | $4,099 | $100 |
| Amlodipine Besylate | 95 | $1,547 | $16 |
| Ultra-Fine Short Pen Needle | 23 | $1,483 | $64 |
| Hydralazine | 58 | $1,310 | $23 |
| Omeprazole | 26 | $1,227 | $47 |
| Tamsulosin | 57 | $1,142 | $20 |
| Metolazone | 11 | $1,108 | $101 |
| Losartan | 72 | $1,104 | $15 |
| Metoprolol | 56 | $909 | $16 |
| Bumetanide | 20 | $907 | $45 |
| Doxazosin Mesylate | 28 | $884 | $32 |
| Atorvastatin | 55 | $839 | $15 |
| Furosemide | 57 | $802 | $14 |
| Lisinopril | 42 | $773 | $18 |
| Gabapentin | 25 | $636 | $25 |
| Carvedilol | 35 | $629 | $18 |
| Calcitriol | 16 | $508 | $32 |
| Gentamicin Sulfate | 15 | $499 | $33 |
| Simvastatin | 24 | $477 | $20 |
| Pantoprazole | 30 | $413 | $14 |
| Valsartan | 11 | $350 | $32 |
| Levothyroxine | 13 | $299 | $23 |
| Paroxetine | 17 | $283 | $17 |
| Prednisone | 18 | $277 | $15 |
| Allopurinol | 17 | $276 | $16 |
| Metformin | 20 | $263 | $13 |
| Lactulose | 11 | $219 | $20 |
| Hydrochlorothiazide | 19 | $198 | $10 |
| Metoprolol | 14 | $196 | $14 |
| Glipizide | 13 | $136 | $10 |
| Ciprofloxacin | 12 | $68 | $6 |
2022: 38 drugs
| Renvela | 38 | $87,523 | $2,303 |
| Sevelamer Carbonate | 39 | $27,868 | $715 |
| Eliquis | 25 | $17,671 | $707 |
| Tacrolimus | 15 | $16,146 | $1,076 |
| Tradjenta | 20 | $15,213 | $761 |
| Lanthanum Carbonate | 14 | $13,285 | $949 |
| Clinisol | 53 | $10,045 | $190 |
| Calcium Acetate | 44 | $8,577 | $195 |
| Novolog Flexpen | 14 | $8,457 | $604 |
| Midodrine | 14 | $4,613 | $330 |
| Amlodipine Besylate | 128 | $1,347 | $11 |
| Potassium Chloride | 14 | $1,057 | $76 |
| Hydralazine | 37 | $1,028 | $28 |
| Atorvastatin | 73 | $996 | $14 |
| Losartan | 85 | $961 | $11 |
| Furosemide | 67 | $881 | $13 |
| Carvedilol | 49 | $714 | $15 |
| Omeprazole | 20 | $692 | $35 |
| Tamsulosin | 46 | $689 | $15 |
| Doxazosin Mesylate | 38 | $534 | $14 |
| Pantoprazole | 30 | $477 | $16 |
| Levothyroxine | 19 | $474 | $25 |
| Metoprolol | 51 | $412 | $8 |
| Metoprolol | 15 | $372 | $25 |
| Lisinopril | 45 | $330 | $7 |
| Clonidine | 15 | $282 | $19 |
| Allopurinol | 15 | $263 | $18 |
| Calcitriol | 14 | $238 | $17 |
| Simvastatin | 26 | $221 | $9 |
| Gabapentin | 16 | $188 | $12 |
| Hydrochlorothiazide | 23 | $183 | $8 |
| Paroxetine | 20 | $178 | $9 |
| Prednisone | 11 | $172 | $16 |
| Metformin | 19 | $137 | $7 |
| Isosorbide Mononitrate Er | 12 | $124 | $10 |
| Levofloxacin | 14 | $84 | $6 |
| Glipizide | 13 | $68 | $5 |
| Famotidine | 11 | $64 | $6 |
2021: 48 drugs
| Renvela | 41 | $77,724 | $1,896 |
| Velphoro | 20 | $30,868 | $1,543 |
| Cinacalcet | 18 | $27,777 | $1,543 |
| Sevelamer Carbonate | 82 | $27,171 | $331 |
| Tacrolimus | 29 | $17,514 | $604 |
| Lanthanum Carbonate | 14 | $14,729 | $1,052 |
| Tradjenta | 16 | $12,398 | $775 |
| Clinisol | 54 | $9,984 | $185 |
| Eliquis | 11 | $8,609 | $783 |
| Calcium Acetate | 70 | $7,100 | $101 |
| Novolog Flexpen | 11 | $6,534 | $594 |
| Midodrine | 19 | $4,372 | $230 |
| Potassium Chloride | 25 | $3,602 | $144 |
| Paricalcitol | 13 | $2,467 | $190 |
| Mycophenolate Mofetil | 20 | $1,515 | $76 |
| Amlodipine Besylate | 184 | $1,506 | $8 |
| Atorvastatin | 99 | $1,453 | $15 |
| Pantoprazole | 58 | $1,285 | $22 |
| Losartan | 95 | $1,271 | $13 |
| Hydralazine | 66 | $1,212 | $18 |
| Doxazosin Mesylate | 46 | $961 | $21 |
| Furosemide | 100 | $943 | $9 |
| Ezetimibe | 15 | $909 | $61 |
| Bumetanide | 13 | $864 | $66 |
| Carvedilol | 59 | $694 | $12 |
| Omeprazole | 37 | $686 | $19 |
| Metoprolol | 63 | $566 | $9 |
| Tamsulosin | 44 | $533 | $12 |
| Lidocaine-Prilocaine | 22 | $517 | $23 |
| Metoprolol | 24 | $512 | $21 |
| Lisinopril | 69 | $444 | $6 |
| Clonidine | 35 | $427 | $12 |
| Valsartan | 11 | $393 | $36 |
| Calcitriol | 14 | $367 | $26 |
| Gabapentin | 27 | $337 | $12 |
| Terazosin | 16 | $327 | $20 |
| Hydrochlorothiazide | 35 | $309 | $9 |
| Prednisone | 27 | $309 | $11 |
| Simvastatin | 25 | $305 | $12 |
| Levothyroxine | 14 | $298 | $21 |
| Allopurinol | 19 | $297 | $16 |
| Hydroxyzine | 13 | $237 | $18 |
| Lactulose | 20 | $214 | $11 |
| Metformin | 16 | $140 | $9 |
| Generlac | 11 | $101 | $9 |
| Atenolol | 12 | $84 | $7 |
| Glipizide | 13 | $46 | $4 |
| Ciprofloxacin | 13 | $38 | $3 |
2020: 45 drugs
| Renvela | 35 | $56,615 | $1,618 |
| Cinacalcet | 22 | $25,467 | $1,158 |
| Veltassa | 20 | $18,090 | $905 |
| Sevelamer Carbonate | 77 | $15,696 | $204 |
| Lanthanum Carbonate | 11 | $13,517 | $1,229 |
| Velphoro | 12 | $10,836 | $903 |
| Clinisol | 57 | $10,044 | $176 |
| Tacrolimus | 27 | $6,137 | $227 |
| Calcium Acetate | 73 | $6,050 | $83 |
| Procrit | 11 | $3,651 | $332 |
| Bumetanide | 24 | $1,995 | $83 |
| Midodrine | 18 | $1,790 | $99 |
| Hydralazine | 63 | $1,350 | $21 |
| Mycophenolate Mofetil | 20 | $1,270 | $63 |
| Amlodipine Besylate | 162 | $1,229 | $8 |
| Potassium Chloride | 18 | $1,182 | $66 |
| Atorvastatin | 82 | $1,100 | $13 |
| Losartan | 81 | $963 | $12 |
| Valsartan | 19 | $926 | $49 |
| Doxazosin Mesylate | 25 | $854 | $34 |
| Megestrol Acetate | 12 | $812 | $68 |
| Furosemide | 94 | $804 | $9 |
| Pantoprazole | 50 | $786 | $16 |
| Levothyroxine | 17 | $477 | $28 |
| Tamsulosin | 37 | $464 | $13 |
| Metoprolol | 73 | $458 | $6 |
| Clonidine | 42 | $451 | $11 |
| Ezetimibe | 12 | $404 | $34 |
| Gabapentin | 32 | $363 | $11 |
| Metoprolol | 22 | $348 | $16 |
| Lisinopril | 47 | $306 | $7 |
| Simvastatin | 32 | $299 | $9 |
| Carvedilol | 24 | $295 | $12 |
| Omeprazole | 38 | $253 | $7 |
| Prednisone | 29 | $227 | $8 |
| Allopurinol | 16 | $209 | $13 |
| Hydrochlorothiazide | 30 | $184 | $6 |
| Hydrocodone-Acetaminophen | 18 | $183 | $10 |
| Terazosin | 20 | $152 | $8 |
| Lactulose | 18 | $138 | $8 |
| Paroxetine | 11 | $96 | $9 |
| Atenolol | 15 | $84 | $6 |
| Ciprofloxacin | 14 | $71 | $5 |
| Alprazolam | 12 | $71 | $6 |
| Cephalexin | 13 | $42 | $3 |
2019: 41 drugs
| Renvela | 44 | $70,522 | $1,603 |
| Sevelamer Carbonate | 64 | $30,489 | $476 |
| Lanthanum Carbonate | 15 | $13,519 | $901 |
| Clinisol | 28 | $5,125 | $183 |
| Calcium Acetate | 75 | $4,931 | $66 |
| Tacrolimus | 17 | $4,658 | $274 |
| Bumetanide | 13 | $1,942 | $149 |
| Amlodipine Besylate | 175 | $1,459 | $8 |
| Hydralazine | 84 | $1,207 | $14 |
| Doxazosin Mesylate | 27 | $1,207 | $45 |
| Midodrine | 13 | $888 | $68 |
| Hydrocodone-Acetaminophen | 28 | $864 | $31 |
| Atorvastatin | 64 | $798 | $12 |
| Valsartan | 26 | $682 | $26 |
| Mycophenolate Mofetil | 12 | $672 | $56 |
| Furosemide | 91 | $619 | $7 |
| Metoprolol | 21 | $614 | $29 |
| Tamsulosin | 39 | $550 | $14 |
| Losartan | 55 | $549 | $10 |
| Metoprolol | 90 | $541 | $6 |
| Calcitriol | 27 | $489 | $18 |
| Allopurinol | 31 | $464 | $15 |
| Omeprazole | 57 | $404 | $7 |
| Clonidine | 40 | $398 | $10 |
| Lisinopril | 37 | $367 | $10 |
| Pantoprazole | 38 | $325 | $9 |
| Gabapentin | 30 | $313 | $10 |
| Loperamide | 14 | $307 | $22 |
| Simvastatin | 34 | $301 | $9 |
| Prednisone | 40 | $274 | $7 |
| Clopidogrel | 16 | $200 | $13 |
| Zolpidem | 16 | $192 | $12 |
| Carvedilol | 22 | $149 | $7 |
| Paroxetine | 14 | $136 | $10 |
| Fluoxetine | 12 | $132 | $11 |
| Hydrochlorothiazide | 17 | $125 | $7 |
| Ranitidine | 14 | $110 | $8 |
| Terazosin | 14 | $103 | $7 |
| Losartan-Hydrochlorothiazide | 13 | $75 | $6 |
| Metformin | 11 | $47 | $4 |
| Cephalexin | 11 | $44 | $4 |
2018: 64 drugs
| Renvela | 97 | $163,807 | $1,689 |
| Sevelamer Carbonate | 64 | $55,411 | $866 |
| Fosrenol | 15 | $17,419 | $1,161 |
| Tacrolimus | 29 | $10,637 | $367 |
| Calcium Acetate | 140 | $9,844 | $70 |
| Lantus Solostar | 18 | $9,606 | $534 |
| Lantus | 13 | $7,706 | $593 |
| Lyrica | 15 | $3,428 | $229 |
| Bumetanide | 20 | $2,834 | $142 |
| Mycophenolate Mofetil | 26 | $1,979 | $76 |
| Hydrocodone-Acetaminophen | 78 | $1,892 | $24 |
| Midodrine | 29 | $1,424 | $49 |
| Amlodipine Besylate | 174 | $1,322 | $8 |
| Calcitriol | 56 | $1,115 | $20 |
| Esomeprazole Magnesium | 13 | $1,080 | $83 |
| Metolazone | 22 | $1,023 | $47 |
| Metoprolol | 32 | $966 | $30 |
| Hydralazine | 63 | $902 | $14 |
| Travasol | 11 | $861 | $78 |
| Lanthanum Carbonate | 17 | $841 | $49 |
| Diphenoxylate-Atropine | 12 | $841 | $70 |
| Atorvastatin | 56 | $678 | $12 |
| Tamsulosin | 37 | $621 | $17 |
| Chlorthalidone | 20 | $596 | $30 |
| Omega-3 Acid Ethyl Esters | 11 | $584 | $53 |
| Metoprolol | 104 | $570 | $5 |
| Furosemide | 124 | $555 | $4 |
| Levothyroxine | 20 | $551 | $28 |
| Potassium Chloride | 14 | $550 | $39 |
| Nifedipine Er | 17 | $536 | $32 |
| Doxazosin Mesylate | 19 | $493 | $26 |
| Morphine Sulfate Er | 12 | $462 | $39 |
| Omeprazole | 73 | $423 | $6 |
| Gabapentin | 50 | $416 | $8 |
| Losartan | 48 | $416 | $9 |
| Carvedilol | 60 | $351 | $6 |
| Ondansetron | 17 | $335 | $20 |
| Zolpidem | 24 | $307 | $13 |
| Pantoprazole | 44 | $296 | $7 |
| Clonidine | 36 | $295 | $8 |
| Prednisone | 54 | $278 | $5 |
| Lisinopril | 42 | $276 | $7 |
| Pravastatin | 11 | $271 | $25 |
| Simvastatin | 50 | $262 | $5 |
| Loperamide | 14 | $252 | $18 |
| Isosorbide Mononitrate Er | 16 | $234 | $15 |
| Paroxetine | 22 | $211 | $10 |
| Clopidogrel | 17 | $205 | $12 |
| Allopurinol | 29 | $193 | $7 |
| Famotidine | 21 | $177 | $8 |
| Terazosin | 25 | $162 | $6 |
| Benazepril | 27 | $141 | $5 |
| Promethazine | 17 | $140 | $8 |
| Atenolol | 13 | $137 | $11 |
| Hydroxyzine | 14 | $123 | $9 |
| Nortriptyline | 14 | $103 | $7 |
| Levofloxacin | 11 | $97 | $9 |
| Alprazolam | 17 | $97 | $6 |
| Hydrochlorothiazide | 21 | $96 | $5 |
| Hydroxyzine Pamoate | 12 | $65 | $5 |
| Glipizide | 23 | $60 | $3 |
| Losartan-Hydrochlorothiazide | 13 | $59 | $5 |
| Ciprofloxacin | 11 | $35 | $3 |
| Diazepam | 12 | $21 | $2 |
2017: 71 drugs
| Renvela | 155 | $249,122 | $1,607 |
| Sensipar | 88 | $145,708 | $1,656 |
| Fosrenol | 26 | $26,310 | $1,012 |
| Lantus Solostar | 33 | $15,535 | $471 |
| Sevelamer Carbonate | 16 | $15,262 | $954 |
| Calcium Acetate | 128 | $8,784 | $69 |
| Humalog | 11 | $7,929 | $721 |
| Januvia | 14 | $6,754 | $482 |
| Novolog Flexpen | 12 | $6,317 | $526 |
| Lantus | 12 | $5,788 | $482 |
| Tacrolimus | 15 | $4,524 | $302 |
| Lyrica | 16 | $3,084 | $193 |
| Esomeprazole Magnesium | 28 | $2,398 | $86 |
| Mycophenolate Mofetil | 28 | $2,307 | $82 |
| Bumetanide | 21 | $1,974 | $94 |
| Hydrocodone-Acetaminophen | 73 | $1,545 | $21 |
| Calcitriol | 57 | $1,224 | $21 |
| Amlodipine Besylate | 229 | $1,206 | $5 |
| Omega-3 Acid Ethyl Esters | 13 | $1,079 | $83 |
| Tamsulosin | 49 | $961 | $20 |
| Travasol | 13 | $939 | $72 |
| Eplerenone | 13 | $917 | $71 |
| Hydralazine | 71 | $901 | $13 |
| Doxazosin Mesylate | 36 | $850 | $24 |
| Omeprazole | 112 | $716 | $6 |
| Levothyroxine | 23 | $649 | $28 |
| Atorvastatin | 50 | $624 | $12 |
| Metoprolol | 133 | $541 | $4 |
| Allopurinol | 33 | $471 | $14 |
| Enalapril Maleate | 22 | $442 | $20 |
| Lisinopril | 75 | $442 | $6 |
| Furosemide | 87 | $441 | $5 |
| Carvedilol | 80 | $419 | $5 |
| Metoprolol | 19 | $419 | $22 |
| Nifedipine Er | 17 | $376 | $22 |
| Clonidine | 46 | $374 | $8 |
| Duloxetine | 13 | $370 | $28 |
| Gabapentin | 60 | $368 | $6 |
| Losartan | 56 | $316 | $6 |
| Simvastatin | 72 | $315 | $4 |
| Loperamide | 16 | $315 | $20 |
| Escitalopram | 20 | $293 | $15 |
| Pen Needle | 13 | $276 | $21 |
| Pantoprazole | 43 | $274 | $6 |
| Prednisone | 37 | $221 | $6 |
| Benazepril | 33 | $205 | $6 |
| Metoclopramide | 26 | $187 | $7 |
| Hydroxyzine | 18 | $167 | $9 |
| Ondansetron | 12 | $164 | $14 |
| Levofloxacin | 11 | $159 | $14 |
| Isosorbide Mononitrate Er | 11 | $155 | $14 |
| Glipizide | 48 | $150 | $3 |
| Trazodone | 28 | $142 | $5 |
| Atenolol | 13 | $135 | $10 |
| Famotidine | 25 | $118 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $106 | $10 |
| Nortriptyline | 15 | $102 | $7 |
| Alprazolam | 15 | $98 | $7 |
| Azithromycin | 13 | $97 | $7 |
| Clopidogrel | 14 | $89 | $6 |
| Losartan-Hydrochlorothiazide | 14 | $86 | $6 |
| Fluoxetine | 14 | $75 | $5 |
| Hydrochlorothiazide | 29 | $62 | $2 |
| Ciprofloxacin | 11 | $62 | $6 |
| Gemfibrozil | 12 | $60 | $5 |
| Hydroxyzine Pamoate | 11 | $59 | $5 |
| Metformin | 12 | $57 | $5 |
| Cephalexin | 11 | $47 | $4 |
| Ibuprofen | 11 | $44 | $4 |
| Lorazepam | 11 | $40 | $4 |
| Diazepam | 13 | $38 | $3 |
2016: 72 drugs
| Renvela | 164 | $251,843 | $1,536 |
| Sensipar | 122 | $163,681 | $1,342 |
| Fosrenol | 54 | $49,397 | $915 |
| Lantus | 31 | $13,662 | $441 |
| Calcium Acetate | 156 | $13,580 | $87 |
| Humalog | 19 | $13,477 | $709 |
| Novolog Flexpen | 20 | $9,996 | $500 |
| Januvia | 15 | $8,054 | $537 |
| Lantus Solostar | 15 | $7,992 | $533 |
| Nexium | 23 | $5,879 | $256 |
| Lyrica | 21 | $5,381 | $256 |
| Tacrolimus | 13 | $3,602 | $277 |
| Clinisol | 23 | $3,438 | $149 |
| Hydrocodone-Acetaminophen | 90 | $2,978 | $33 |
| Valsartan | 16 | $1,918 | $120 |
| Hydralazine | 107 | $1,635 | $15 |
| Verapamil | 12 | $1,616 | $135 |
| Esomeprazole Magnesium | 16 | $1,435 | $90 |
| Calcitriol | 55 | $1,405 | $26 |
| Amlodipine Besylate | 226 | $1,317 | $6 |
| Omega-3 Acid Ethyl Esters | 13 | $1,143 | $88 |
| Levothyroxine | 44 | $946 | $22 |
| Doxazosin Mesylate | 52 | $923 | $18 |
| Atorvastatin | 63 | $884 | $14 |
| Mycophenolate Mofetil | 13 | $854 | $66 |
| Tamsulosin | 34 | $794 | $23 |
| Eplerenone | 11 | $750 | $68 |
| Metoprolol | 28 | $729 | $26 |
| Omeprazole | 115 | $716 | $6 |
| Gabapentin | 85 | $694 | $8 |
| Bumetanide | 18 | $636 | $35 |
| Diltiazem 24hr Er | 14 | $626 | $45 |
| Terazosin | 20 | $591 | $30 |
| Metoprolol | 150 | $560 | $4 |
| Carvedilol | 75 | $531 | $7 |
| Allopurinol | 37 | $527 | $14 |
| Enalapril Maleate | 24 | $511 | $21 |
| Losartan | 32 | $445 | $14 |
| Zolpidem | 18 | $428 | $24 |
| Lisinopril | 86 | $418 | $5 |
| Simvastatin | 82 | $414 | $5 |
| Furosemide | 109 | $409 | $4 |
| Midodrine | 11 | $353 | $32 |
| Benazepril | 48 | $353 | $7 |
| Prednisone | 35 | $350 | $10 |
| Insulin | 14 | $342 | $24 |
| Pravastatin | 22 | $315 | $14 |
| Escitalopram | 19 | $275 | $14 |
| Nifedipine Er | 12 | $223 | $19 |
| Amoxicillin-Clavulanate Potass | 15 | $212 | $14 |
| Pantoprazole | 19 | $200 | $11 |
| Ibuprofen | 24 | $198 | $8 |
| Atenolol | 31 | $175 | $6 |
| Clopidogrel | 35 | $175 | $5 |
| Lactulose | 22 | $164 | $7 |
| Clonidine | 28 | $160 | $6 |
| Nifedical Xl | 14 | $160 | $11 |
| Alprazolam | 23 | $158 | $7 |
| Trazodone | 27 | $147 | $5 |
| Glimepiride | 20 | $141 | $7 |
| Losartan-Hydrochlorothiazide | 14 | $140 | $10 |
| Levofloxacin | 12 | $134 | $11 |
| Paroxetine | 12 | $123 | $10 |
| Mirtazapine | 11 | $117 | $11 |
| Metformin | 28 | $87 | $3 |
| Glipizide | 31 | $85 | $3 |
| Metoclopramide | 12 | $77 | $6 |
| Gemfibrozil | 12 | $76 | $6 |
| Cephalexin | 16 | $70 | $4 |
| Hydrochlorothiazide | 12 | $49 | $4 |
| Diazepam | 12 | $24 | $2 |
| Famotidine | 13 | $24 | $2 |
2015: 76 drugs
| Renvela | 176 | $225,304 | $1,280 |
| Sensipar | 119 | $143,584 | $1,207 |
| Fosrenol | 66 | $54,362 | $824 |
| Clinisol | 150 | $21,252 | $142 |
| Calcium Acetate | 159 | $16,928 | $106 |
| Lantus | 25 | $11,471 | $459 |
| Novolog Flexpen | 22 | $9,793 | $445 |
| Novolog | 15 | $8,405 | $560 |
| Lyrica | 28 | $6,756 | $241 |
| Lantus Solostar | 20 | $6,390 | $319 |
| Januvia | 19 | $6,351 | $334 |
| Nexium | 25 | $6,189 | $248 |
| Levemir Flextouch | 12 | $4,602 | $383 |
| Crestor | 12 | $3,998 | $333 |
| Hydrocodone-Acetaminophen | 107 | $3,466 | $32 |
| Clonidine | 15 | $2,682 | $179 |
| Esomeprazole Magnesium | 11 | $2,118 | $193 |
| Hydralazine | 141 | $2,035 | $14 |
| Calcitriol | 58 | $1,394 | $24 |
| Amlodipine Besylate | 244 | $1,392 | $6 |
| Tamsulosin | 34 | $1,353 | $40 |
| Valsartan | 13 | $1,237 | $95 |
| Metoprolol | 48 | $1,224 | $26 |
| Verapamil | 12 | $1,144 | $95 |
| Levothyroxine | 42 | $949 | $23 |
| Bumetanide | 22 | $938 | $43 |
| Omeprazole | 129 | $904 | $7 |
| Oxycodone-Acetaminophen | 11 | $875 | $80 |
| Benazepril | 89 | $856 | $10 |
| Furosemide | 129 | $821 | $6 |
| Bd Ultra-Fine Pen Needle | 13 | $792 | $61 |
| Doxazosin Mesylate | 29 | $694 | $24 |
| Losartan | 56 | $674 | $12 |
| Allopurinol | 49 | $668 | $14 |
| Enalapril Maleate | 25 | $622 | $25 |
| Simvastatin | 112 | $563 | $5 |
| Synthroid | 12 | $555 | $46 |
| Metoprolol | 139 | $505 | $4 |
| Gabapentin | 65 | $502 | $8 |
| Mycophenolate Mofetil | 13 | $483 | $37 |
| Insulin | 21 | $477 | $23 |
| Atorvastatin | 40 | $422 | $11 |
| Insulin | 16 | $412 | $26 |
| Nifedipine Er | 15 | $392 | $26 |
| Isosorbide Dinitrate | 13 | $383 | $29 |
| Carvedilol | 57 | $352 | $6 |
| Pravastatin | 26 | $340 | $13 |
| Chlorthalidone | 18 | $340 | $19 |
| Hydromorphone | 11 | $325 | $30 |
| Lisinopril | 66 | $315 | $5 |
| Alprazolam | 37 | $296 | $8 |
| Clonidine | 34 | $277 | $8 |
| Pioglitazone | 19 | $264 | $14 |
| Prednisone | 38 | $259 | $7 |
| Zolpidem | 18 | $235 | $13 |
| Metoclopramide | 22 | $143 | $7 |
| Amoxicillin-Clavulanate Potass | 17 | $143 | $8 |
| Escitalopram | 18 | $139 | $8 |
| Atenolol | 34 | $138 | $4 |
| Diltiazem 24hr Cd | 11 | $131 | $12 |
| Glimepiride | 21 | $122 | $6 |
| Metformin | 30 | $120 | $4 |
| Lactulose | 12 | $112 | $9 |
| Pantoprazole | 15 | $106 | $7 |
| Clopidogrel | 20 | $103 | $5 |
| Hydrochlorothiazide | 21 | $102 | $5 |
| Glipizide Xl | 11 | $98 | $9 |
| Warfarin | 23 | $92 | $4 |
| Gemfibrozil | 13 | $82 | $6 |
| Ciprofloxacin | 16 | $74 | $5 |
| Cephalexin | 18 | $70 | $4 |
| Paroxetine | 12 | $69 | $6 |
| Pramipexole Dihydrochloride | 12 | $53 | $4 |
| Diazepam | 15 | $52 | $3 |
| Glipizide | 16 | $41 | $3 |
| Famotidine | 13 | $27 | $2 |
2014: 76 drugs
| Renvela | 176 | $146,602 | $833 |
| Sensipar | 117 | $122,659 | $1,048 |
| Fosrenol | 61 | $45,491 | $746 |
| Renagel | 19 | $28,593 | $1,505 |
| Calcium Acetate | 176 | $21,100 | $120 |
| Clinisol | 125 | $18,581 | $149 |
| Humalog | 40 | $15,572 | $389 |
| Lantus | 26 | $11,757 | $452 |
| Sevelamer Carbonate | 16 | $11,051 | $691 |
| Novolog Flexpen | 19 | $9,575 | $504 |
| Nexium | 35 | $9,279 | $265 |
| Novolog | 17 | $8,910 | $524 |
| Diovan | 34 | $7,651 | $225 |
| Clonidine | 19 | $4,175 | $220 |
| Januvia | 13 | $3,853 | $296 |
| Lantus Solostar | 11 | $3,756 | $341 |
| Duloxetine | 15 | $3,570 | $238 |
| Lyrica | 13 | $3,189 | $245 |
| Hydrocodone-Acetaminophen | 127 | $2,985 | $24 |
| Hydralazine | 99 | $2,328 | $24 |
| Calcitriol | 56 | $2,227 | $40 |
| Bd Ultra-Fine Pen Needle | 35 | $1,693 | $48 |
| Amlodipine Besylate | 199 | $1,685 | $8 |
| Mycophenolate Mofetil | 19 | $1,601 | $84 |
| Oxycodone-Acetaminophen | 11 | $1,432 | $130 |
| Omeprazole | 161 | $1,330 | $8 |
| Proair Hfa | 27 | $1,319 | $49 |
| Metoprolol | 31 | $1,175 | $38 |
| Paricalcitol | 11 | $1,015 | $92 |
| Novolin R | 11 | $1,010 | $92 |
| Furosemide | 179 | $907 | $5 |
| Levothyroxine | 56 | $867 | $15 |
| Tamsulosin | 33 | $836 | $25 |
| Atorvastatin | 57 | $781 | $14 |
| Doxazosin Mesylate | 30 | $741 | $25 |
| Bumetanide | 12 | $724 | $60 |
| Verapamil | 12 | $715 | $60 |
| Losartan | 60 | $702 | $12 |
| Insulin | 33 | $699 | $21 |
| Afeditab Cr | 15 | $698 | $47 |
| Diltiazem 24hr Er | 20 | $672 | $34 |
| Carvedilol | 68 | $662 | $10 |
| Nifedipine Er | 14 | $656 | $47 |
| Simvastatin | 94 | $632 | $7 |
| Metoprolol | 139 | $618 | $4 |
| Benazepril | 72 | $611 | $8 |
| Pioglitazone | 20 | $576 | $29 |
| Pravastatin | 23 | $563 | $24 |
| Gabapentin | 66 | $504 | $8 |
| Allopurinol | 73 | $423 | $6 |
| Lisinopril | 53 | $411 | $8 |
| Enalapril Maleate | 31 | $361 | $12 |
| Clonidine | 36 | $321 | $9 |
| Ramipril | 38 | $296 | $8 |
| Glipizide Er | 14 | $254 | $18 |
| Alprazolam | 33 | $242 | $7 |
| Diltiazem 24hr Cd | 13 | $237 | $18 |
| Clopidogrel | 30 | $227 | $8 |
| Lactulose | 12 | $224 | $19 |
| Amox Tr-Potassium Clavulanate | 18 | $197 | $11 |
| Metoclopramide | 25 | $182 | $7 |
| Terazosin | 20 | $181 | $9 |
| Hydrochlorothiazide | 18 | $176 | $10 |
| Metformin | 25 | $162 | $6 |
| Glipizide Xl | 16 | $146 | $9 |
| Prednisone | 23 | $145 | $6 |
| Glimepiride | 25 | $127 | $5 |
| Warfarin | 23 | $123 | $5 |
| Tramadol | 16 | $113 | $7 |
| Atenolol | 24 | $111 | $5 |
| Ibuprofen | 14 | $103 | $7 |
| Bisoprolol-Hydrochlorothiazide | 11 | $97 | $9 |
| Famotidine | 21 | $89 | $4 |
| Zolpidem | 12 | $81 | $7 |
| Gemfibrozil | 12 | $79 | $7 |
| Ciprofloxacin | 12 | $41 | $3 |
2013: 87 drugs
| Renvela | 284 | $194,158 | $684 |
| Sensipar | 173 | $141,341 | $817 |
| Renagel | 19 | $23,018 | $1,211 |
| Fosrenol | 23 | $20,899 | $909 |
| Clinisol | 53 | $19,663 | $371 |
| Calcium Acetate | 162 | $17,255 | $107 |
| Lantus | 32 | $12,909 | $403 |
| Myfortic | 12 | $11,954 | $996 |
| Novolog Flexpen | 27 | $11,643 | $431 |
| Humalog | 27 | $8,832 | $327 |
| Nexium | 36 | $8,239 | $229 |
| Novolog | 18 | $6,205 | $345 |
| Lantus Solostar | 18 | $6,029 | $335 |
| Diovan | 33 | $5,551 | $168 |
| Zemplar | 23 | $4,991 | $217 |
| Clonidine | 17 | $4,432 | $261 |
| Hectorol | 12 | $4,171 | $348 |
| Micardis | 17 | $3,586 | $211 |
| Effient | 15 | $3,408 | $227 |
| Lyrica | 17 | $3,345 | $197 |
| Hydrocodone-Acetaminophen | 128 | $2,808 | $22 |
| Hydralazine | 105 | $2,754 | $26 |
| Crestor | 13 | $2,527 | $194 |
| Midodrine | 26 | $2,151 | $83 |
| Omeprazole | 170 | $2,000 | $12 |
| Amlodipine Besylate | 192 | $1,940 | $10 |
| Lovaza | 12 | $1,861 | $155 |
| Colcrys | 11 | $1,836 | $167 |
| Nifedipine Er | 33 | $1,649 | $50 |
| Mycophenolate Mofetil | 16 | $1,553 | $97 |
| Niaspan | 13 | $1,361 | $105 |
| Simvastatin | 165 | $1,325 | $8 |
| Bd Ultra-Fine Pen Needle | 23 | $1,161 | $50 |
| Atorvastatin | 46 | $1,098 | $24 |
| Proair Hfa | 23 | $1,084 | $47 |
| Furosemide | 196 | $1,060 | $5 |
| Novolin R | 12 | $1,056 | $88 |
| Metoprolol | 164 | $949 | $6 |
| Tamsulosin | 37 | $886 | $24 |
| Calcitriol | 22 | $846 | $38 |
| Clopidogrel | 18 | $820 | $46 |
| Metoprolol | 25 | $784 | $31 |
| Insulin | 29 | $772 | $27 |
| Verapamil | 12 | $758 | $63 |
| Carvedilol | 72 | $733 | $10 |
| Benazepril | 87 | $727 | $8 |
| Losartan | 53 | $712 | $13 |
| Gabapentin | 74 | $692 | $9 |
| Diltiazem 24hr Er | 19 | $642 | $34 |
| Oxycodone Hcl-Acetaminophen | 11 | $622 | $57 |
| Insulin | 26 | $594 | $23 |
| Ramipril | 55 | $550 | $10 |
| Lisinopril | 68 | $485 | $7 |
| Levothyroxine | 60 | $460 | $8 |
| Labetalol | 12 | $454 | $38 |
| Doxazosin Mesylate | 36 | $442 | $12 |
| Synthroid | 22 | $441 | $20 |
| Allopurinol | 78 | $426 | $5 |
| Clonidine | 41 | $418 | $10 |
| Bumetanide | 19 | $365 | $19 |
| Megestrol Acetate | 19 | $350 | $18 |
| Pravastatin | 23 | $348 | $15 |
| Isosorbide Mononitrate Er | 18 | $332 | $18 |
| Metoclopramide | 40 | $327 | $8 |
| Insulin | 12 | $317 | $26 |
| Glipizide Er | 26 | $298 | $11 |
| Warfarin | 26 | $283 | $11 |
| Diltiazem 24hr Cd | 11 | $255 | $23 |
| Metolazone | 15 | $246 | $16 |
| Hydrochlorothiazide | 26 | $243 | $9 |
| Tramadol | 24 | $239 | $10 |
| Prednisone | 58 | $236 | $4 |
| Potassium Chloride | 14 | $233 | $17 |
| Glipizide | 24 | $224 | $9 |
| Glimepiride | 20 | $193 | $10 |
| Enalapril Maleate | 22 | $185 | $8 |
| Metformin | 22 | $168 | $8 |
| Azithromycin | 17 | $163 | $10 |
| Ciprofloxacin | 17 | $157 | $9 |
| Atenolol | 30 | $150 | $5 |
| Alprazolam | 22 | $133 | $6 |
| Famotidine | 28 | $130 | $5 |
| Zolpidem | 15 | $114 | $8 |
| Ibuprofen | 19 | $99 | $5 |
| Bisoprolol-Hydrochlorothiazide | 12 | $98 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $79 | $7 |
| Diazepam | 12 | $41 | $3 |
Money from drug and device companies
$108 in 2025
| 2025 | 2 | 5 | None | $108 |
| 2024 | 6 | 7 | None | $260 |
| 2023 | 3 | 3 | None | $53 |
| 2022 | 2 | 3 | None | $69 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 4 | 4 | None | $72 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Evenity | $84 | 4 payments
|
| Calliditas Therapeutics US | Tarpeyo | $24 | 1 payment
|
See all 5 published payments
| Amgen | Meals · 2025-08-04 | Evenity | $23 |
| Amgen | Meals · 2025-07-02 | Krystexxa | $17 |
| Amgen | Meals · 2025-06-02 | Evenity | $20 |
| Amgen | Meals · 2025-03-03 | Tavneos | $25 |
| Calliditas Therapeutics US | Meals · 2025-02-10 | Tarpeyo | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $260
| Travere Therapeutics | None | $119 | 1 payment
|
| Amgen | Aranesp | $53 | 2 payments
|
| GlaxoSmithKline | Jesduvroq | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $23 | 1 payment
|
| Boston Scientific | None | $21 | 1 payment
|
| Octapharma USA | Octagam Immune Globulin (Human) | $20 | 1 payment
|
2023: $53
| Genzyme | Fabrazyme | $22 | 1 payment
|
| Lilly USA | Jardiance | $17 | 1 payment
|
| Amgen | Aranesp | $14 | 1 payment
|
2022: $69
| Vifor Pharma | Veltassa | $53 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
2021: $17
| Vifor Pharma | Veltassa | $17 | 1 payment
|
2020: $21
| Relypsa | Veltassa | $21 | 1 payment
|
2019: $72
| Relypsa | Veltassa | $22 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $19 | 1 payment
|
| Baxter Healthcare | Renal - Crrt | $17 | 1 payment
|
| Daiichi Sankyo | Injectafer | $13 | 1 payment
|
Professional record
- NPI
- 1265511273
- Licence
- CA G507670
- Trained
- University of California, Geffen School of Medicine, 1982
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G507670
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 917 Blanco Circle, Salinas, CA, 93901
- NPI first listed
- 2006-11-02
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.